HCPCS Level II code J3357 represents ustekinumab, for subcutaneous injection, 1 mg, used to report administration of the biologic medication in outpatient or clinic settings for conditions treated with subcutaneous ustekinumab; the service type is drug administration (subcutaneous biologic) and the typical site of service is outpatient clinic or physician office.

For related coverage guidance, see recent payer policy updates: Epithelial Cell Cytology in Breast Cancer Risk Assessment, Antibody-Drug Conjugates, Chemotherapy Observation or Inpatient Hospitalization (for New Mexico Only).